Report Detail
(Post-pandemic Era)-Global Fragment-based Drug Discovery Market Segment Research Report 2022
- RnM3726378 |
- 04 August, 2022 |
- Global |
- 111 Pages |
- XYZResearch |
- Pharma & Healthcare
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Fragment-based Drug Discovery Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Fragment-based Drug Discovery industry at home and abroad, estimate the overall market scale of the Fragment-based Drug Discovery industry and the market share of major countries, Fragment-based Drug Discovery industry, and study and judge the downstream market demand of Fragment-based Drug Discovery through systematic research, Analyze the competition pattern of Fragment-based Drug Discovery, so as to help solve the pain points of various stakeholders in Fragment-based Drug Discovery industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Fragment-based Drug Discovery Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Fragment-based Drug Discovery Market?
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Major Type of Fragment-based Drug Discovery Covered in XYZResearch report:
Fragment Screening
Fragment Optimization
Application Segments Covered in XYZResearch Market
Academic and Research Institutions
Biopharmaceutical Companies
Contract Research Organizations (CROs)
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Fragment-based Drug Discovery Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Fragment-based Drug Discovery Market by Value
- 2.2.1 Global Fragment-based Drug Discovery Revenue by Type
- 2.2.2 Global Fragment-based Drug Discovery Market by Value (%)
- 2.3 Global Fragment-based Drug Discovery Market by Production
- 2.3.1 Global Fragment-based Drug Discovery Production by Type
- 2.3.2 Global Fragment-based Drug Discovery Market by Production (%)
3. The Major Driver of Fragment-based Drug Discovery Industry
- 3.1 Historical & Forecast Global Fragment-based Drug Discovery Demand
- 3.2 Largest Application for Fragment-based Drug Discovery (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Fragment-based Drug Discovery Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Fragment-based Drug Discovery Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Fragment-based Drug Discovery Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Fragment-based Drug Discovery Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Fragment-based Drug Discovery Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Fragment-based Drug Discovery Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Fragment-based Drug Discovery Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Fragment-based Drug Discovery Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Fragment-based Drug Discovery Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Fragment-based Drug Discovery Average Price Trend
- 12.1 Market Price for Each Type of Fragment-based Drug Discovery in US (2018-2022)
- 12.2 Market Price for Each Type of Fragment-based Drug Discovery in Europe (2018-2022)
- 12.3 Market Price for Each Type of Fragment-based Drug Discovery in China (2018-2022)
- 12.4 Market Price for Each Type of Fragment-based Drug Discovery in Japan (2018-2022)
- 12.5 Market Price for Each Type of Fragment-based Drug Discovery in India (2018-2022)
- 12.6 Market Price for Each Type of Fragment-based Drug Discovery in Korea (2018-2022)
- 12.7 Market Price for Each Type of Fragment-based Drug Discovery in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Fragment-based Drug Discovery Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Fragment-based Drug Discovery
14. Fragment-based Drug Discovery Competitive Landscape
- 14.1 Astex Pharmaceuticals
- 14.1.1 Astex Pharmaceuticals Company Profiles
- 14.1.2 Astex Pharmaceuticals Product Introduction
- 14.1.3 Astex Pharmaceuticals Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 Alveus Pharmaceuticals
- 14.2.1 Alveus Pharmaceuticals Company Profiles
- 14.2.2 Alveus Pharmaceuticals Product Introduction
- 14.2.3 Alveus Pharmaceuticals Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 Beactica
- 14.3.1 Beactica Company Profiles
- 14.3.2 Beactica Product Introduction
- 14.3.3 Beactica Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Charles River Laboratories
- 14.4.1 Charles River Laboratories Company Profiles
- 14.4.2 Charles River Laboratories Product Introduction
- 14.4.3 Charles River Laboratories Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 Crown Bioscience
- 14.5.1 Crown Bioscience Company Profiles
- 14.5.2 Crown Bioscience Product Introduction
- 14.5.3 Crown Bioscience Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Emerald BioStructures
- 14.6.1 Emerald BioStructures Company Profiles
- 14.6.2 Emerald BioStructures Product Introduction
- 14.6.3 Emerald BioStructures Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 Evotec
- 14.7.1 Evotec Company Profiles
- 14.7.2 Evotec Product Introduction
- 14.7.3 Evotec Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Kinetic Discovery
- 14.8.1 Kinetic Discovery Company Profiles
- 14.8.2 Kinetic Discovery Product Introduction
- 14.8.3 Kinetic Discovery Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Proteros Fragments
- 14.9.1 Proteros Fragments Company Profiles
- 14.9.2 Proteros Fragments Product Introduction
- 14.9.3 Proteros Fragments Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 Sprint Bioscience
- 14.10.1 Sprint Bioscience Company Profiles
- 14.10.2 Sprint Bioscience Product Introduction
- 14.10.3 Sprint Bioscience Fragment-based Drug Discovery Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
- 14.11 Structure Based Design
- 14.12 Sygnature Discovery
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Fragment-based Drug Discovery. Industry analysis & Market Report on Fragment-based Drug Discovery is a syndicated market report, published as (Post-pandemic Era)-Global Fragment-based Drug Discovery Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Fragment-based Drug Discovery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
